Second trimester estimated fetal weight and fetal weight gain predict childhood obesity

Margaret Parker1, Sheryl L Rifas-Shiman, Emily Oken

  • 1Division of Neonatology, Department of Pediatrics, Boston Medical Center, Boston University School of Medicine, Boston, MA 02118, USA. margaret.parker@bmc.org

Insights

Rapid fetal weight gain and consistently high fetal weight in the second half of pregnancy are linked to higher childhood adiposity. This suggests fetal growth rate impacts future obesity risk.

Area of Science:

  • Pediatric Endocrinology
  • Prenatal Development
  • Public Health Nutrition

Background:

  • Fetal growth influences childhood health outcomes.
  • Understanding predictors of childhood adiposity is crucial for preventative strategies.

Purpose of the Study:

  • To investigate the association between fetal weight and weight gain with adiposity and blood pressure at age 3.
  • To determine if mid-pregnancy fetal weight and subsequent growth predict later adiposity.

Main Methods:

  • Utilized ultrasound biometry to estimate fetal weight at 16-20 weeks gestation in 438 children.
  • Analyzed fetal weight gain by tracking weight quartiles from the second trimester to birth.
  • Measured child's height, weight, skinfold thickness, and blood pressure at age 3.

Main Results:

  • Higher fetal weight in mid-pregnancy and at birth correlated with increased body mass index (BMI) z-scores at age 3.
  • Rapid fetal weight gain and sustained high fetal weight predicted higher BMI z-scores.
  • No significant associations were found with skinfold thickness or systolic blood pressure.

Conclusions:

  • Accelerated fetal weight gain and persistently high fetal weight during late gestation are associated with increased childhood adiposity.
  • The rate of fetal growth throughout pregnancy may be a critical factor for future obesity risk.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...